Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noam Erez

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|November 18, 2008
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpoxNir Paran, Yasemin Suezer, Shlomo Lustig, et al.
Microbiology Spectrum|September 22, 2023
Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralizationTal Noy-Porat, Hadas Tamir, Ron Alcalay, et al.
Scientific Reports|November 6, 2020
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatmentsYaron Vagima, David Gur, Noam Erez, et al.
Emerging Infectious Diseases|March 9, 2019
Diagnosis of Imported Monkeypox, Israel, 2018Noam Erez, Hagit Achdout, Elad Milrot, et al.
Vaccines|May 25, 2024
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike VaccineYfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, et al.
Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Frontiers in Bioengineering and Biotechnology|October 18, 2021
Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination EfficacySharon Melamed, Boaz Politi, Ettie Grauer, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|November 18, 2008
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpoxNir Paran, Yasemin Suezer, Shlomo Lustig, et al.
Microbiology Spectrum|September 22, 2023
Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralizationTal Noy-Porat, Hadas Tamir, Ron Alcalay, et al.
Scientific Reports|November 6, 2020
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatmentsYaron Vagima, David Gur, Noam Erez, et al.
Emerging Infectious Diseases|March 9, 2019
Diagnosis of Imported Monkeypox, Israel, 2018Noam Erez, Hagit Achdout, Elad Milrot, et al.
Vaccines|May 25, 2024
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike VaccineYfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, et al.
Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Frontiers in Bioengineering and Biotechnology|October 18, 2021
Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination EfficacySharon Melamed, Boaz Politi, Ettie Grauer, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Pageof 6